C15-functionalized 16-Ene-1α,25-dihydroxyvitamin D 3 is a new vitamin D analog with unique biological properties

Anticancer Research

Volumn 32, Issue 1 PART 2, 2012, Pages 311-317

  Kumagai, Go ^a   Takano, Masashi ^a   Shindo, Kanako ^a   Sawada, Daisuke ^a   Saito, Nozomi ^a,d   Saito, Hiroshi ^b   Kakuda, Shinji ^b   Takagi, Ken Ichiro ^b   Takimoto Kamimura, Midori ^b   Takenouchi, Kazuya ^b   Chen, Tai C ^c   Kittaka, Atsushi ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TEIJIN PHARMA LIMITED   (Japan)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

15 substituted vitamin D 3; 16 ene vitamin D 3; S N2 reaction

Indexed keywords

9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; OSTEOCALCIN; VITAMIN D DERIVATIVE;

BINDING AFFINITY; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HYPOCALCEMIA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION;

BONE NEOPLASMS; CELL DIFFERENTIATION; HUMANS; HYDROXYCHOLECALCIFEROLS; OSTEOCALCIN; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 84862955879     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Baggiolini EG, Iacobelli JA, Hennessy BM and Uskoković MR: Stereoselective total synthesis of 1α,25-dihydroxycholecalciferol. J Am Chem Soc 104: 2945-2948, 1982.
2. Dauben WG and Brookhart T: Stereocontrolled synthesis of steroidal side chains. J Am Chem Soc 103: 237-238, 1981.
3. Batcho AD, Berger DE, Uskoković MR and Snider BB: C-20 Stereospecific introduction of a steroid side chain. J Am Chem Soc 103: 1293-1295, 1981. (Pubitemid 11107308)
4. 3. J Med Chem 52: 2204-2213, 2009.
5. Swami S, Zhao XY, Sarabia S, Siu-Caldera ML, Uskokovic M, Reddy SG, Feldman D: A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). In: Vitamin D analogs in cancer prevention and therapy. Recent results in cancer research 164. Reichrath J, Friedrich M and Tilgen W (eds.). Springer-Verlag, Berlin, pp. 349-352, 2003.
6. Uskoković MR, Baggiolini E, Shiuey SJ, Iacobelli J, Hennessy B, Kiegiel J, Daniewski AR, Pizzolato G, Courtney LF and Horst RL: The 16-ene analogs of 1,25-dihydroxycholecalciferol. Synthesis and biological activity. In: Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical Application. Norman AW, Bouillon R and Thomasset M (eds.). Walter de Gruyter, Berlin, pp. 139-145, 1991.
7. von Daehne W, Hansen CM, Hansen D and Mathiasen IS: Synthesis and biological activity of new side chain analogues of 16-dehydrocalcitriol and its 20-epimer. In: Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. Norman AW, Bouillon R, and Thomasset M (eds.). Vitamin D Workshop, Inc, Riverside, CA, pp. 81-82, 1997.
8. 3: synthesis and preliminary biological evaluation. J Med Chem 42: 3425-3435, 1999.
9. Posner GH, Lee JK, Wang Q, Peleg S, Burke M, Brem H, Dolan P and Kensler TW: Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1α,25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation. J Med Chem 41: 3008-3014, 1998. (Pubitemid 28359936)
10. 3: design, synthesis, and preliminary biological evaluation. J Org Chem 62: 3299-3314, 1997.
11. Uskoković MR, Studzinski GP and Reddy GS: The 16-ene vitamin D analogs. In: Vitamin D. Feldman D, Glorieux FH and Pike JW (eds.). Academic Press, New York, Chapter 62, pp. 1045-1070, 1997.
12. 3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cells. J Nutr Biochem 4: 49-57, 1993.
13. 3 and its analogs. J Bone Miner Res 9: 1277-1288, 1994.
14. 3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells. J Steroid Biochem Mol Biol 59: 405-412, 1996.
15. 3 is a potent antileukemic agent with low potential to cause hypercalcemia. Leuk Res 18: 453-463, 1994.
16. 3. Arch Biochem Biophys 509: 33-43, 2011.
17. 3 and C-20 analogues. J Org Chem 64: 3196-3206, 1999 and references therein.
18. 3. Org Lett 13: 2852-2855, 2011.
19. Larsen SD, Spilman CH, Yagi Y, Dinh DM, Hart KL and Hess GF: Design and synthesis of seco-oxysterol analogs as potential inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase gene transcription. J Med Chem 37: 2343-2351, 1994. (Pubitemid 24262323)
20. Trost BM, Dumas J and Villa M: New strategies for the synthesis of vitamin D metabolites via Pd-catalyzed reactions. J Am Chem Soc 114: 9836-9845, 1992. (Pubitemid 23021941)
21. 3 and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20. J Med Chem 43: 4247-4265, 2000.
22. 3 analogues with a double side chain: marked cell differentiation activity. Bioorg Med Chem Lett 12: 3255-3258, 2002.
23. 3 analogues utilizing Grignard reaction towards methyl 2,3-anhydro-4,6-o-benzylidene- α-D-mannopyranoside. Heterocycles 67: 327-228, 2003.
24. Ozono K, Liao J, Kerner SA, Scott RA and Pike JW: The vitamin D-responsive element in the human osteocalcin promoter. J Biol Chem 265: 21881-21888, 1990.
25. Drefahl G, Ponsolt K and Schick H: Synthesen von Alkyliden-Steroiden durch Wittig-Reaktion. Chem Ber 98: 604-612, 1965.
26. Marino JP and Abe H: A new stereospecific approach to steroid side chains: conversion of dehydroepiandrosterone to cholesterol, isocholesterol, and their 15β-hydroxy derivatives. J Am Chem Soc 103: 2907-2909, 1981.
27. Takahashi T, Ootake A, Tsuji J and Tachibana K: Regio- and stereoselective 15β-hydroxy group and side chains to steroids by the palladium-catalysed reaction of 1,3-diene monoepoxides with carbonucleophiles. Tetrahedron 41: 5747-5754, 1985.
28. Moon S, Stuhmiller LM, Chadha RK and McMorris TC: Synthesis of dehydro-oogoniol and oogoniol: the adrenosterone route. Tetrahedron 46: 2287-2306, 1990.
29. Wiersig JR, Waespe-Sarcevic N and Djerassi C: Stereospecific synthesis of the side chain of the steroidal plant sex hormone oogoniol. J Org Chem 44: 3374-3382, 1979. (Pubitemid 10192370)
30. Tachibana K, Sakaitanai M and Nakanishi K: Pavoninins: shark-repelling ichthyotoxins from the defense secretion of the pacific sole. Science 226: 703-705, 1984. (Pubitemid 15202151)
31. Gong H and Williams JR: Synthesis of the aglycone of the shark repellent pavoninin-4 using remote functionalization. Org Lett 8: 2253-2255, 2006. (Pubitemid 43998230)
32. N2′ displacements by organocuprate reagents. Tetrahedron Lett 25: 3063-3066, 1984.
33. 3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis. Steroids 66: 327-337, 2001.
34. Sawada D, Tsukuda Y, Saito H, Kakuda S, Takimoto-Kamimura M, Ochiai E, Takenouchi K and Kittaka A: Development of 14-epi-19-nortachysterol and its unprecedented binding configuration for the human vitamin D receptor. J Am Chem Soc 133: 7215-7221, 2011.
35. Saitoh H, Chida T, Takagi K, Horie K, Sawai Y, Nakamura Y, Harada Y, Takenouchi K and Kittaka A: Synthesis of C-2 substituted vitamin D derivatives having ringed side chains and biological evaluation, especially biological effect on bone by modification at C-2 position. Org Biomol Chem 9: 3954-3964, 2011.
36. Chen TC and Kittaka A: Novel Vitamin D Analogs for Prostate Cancer Therapy. International Scholarly Research Network (ISRN) Urology 2011: Article ID 301490, 9 pages, 2011.